Boston Scientific (BSX) Misses Q1 EPS by 1c, Beats on Revenue; Lowers FY EPS Guidance, Raises FY Revenue Guide
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Go back to Boston Scientific (BSX) Misses Q1 EPS by 1c, Beats on Revenue; Lowers FY EPS Guidance, Raises FY Revenue Guide
April 27, 2017 3:58 PM EDT
Needham & Company raised its price target on Boston Scientific (NYSE: BSX) to $30.00 (from $29.00) while maintaining a Buy rating.
...
More
April 27, 2017 3:55 PM EDT
Stifel raised its price target on Boston Scientific (NYSE: BSX) to $30.00 (from $28.00) while maintaining a Buy rating.
...
More
April 27, 2017 1:03 PM EDT
Cowen raised its price target on Boston Scientific (NYSE: BSX) to $31.00 (from $29.00) while maintaining a Outperform rating amid "robust" top-line performance.
Analyst Joshua Jennings said the reason the company gave for the margin shortfall - non-recurring expenses- is "very plausible" and they... More
April 27, 2017 12:00 PM EDT
Evercore ISI raised its price target on Boston Scientific (NYSE: BSX) to $28.50 (from $26.50) while maintaining a Outperform rating after the company "curshed" it on revenues for the quarter.
Analyst Vijay Kumar, "In large cap land, organic revenue beats of >400 bps... More
